Report Detail

Request for Sample of this report

Pharma & Healthcare Global Guaifenesin (API) Market Insights, Forecast to 2025

  • RnM2931849
    • |
  • 12 February, 2019
    • |
  • Global
    • |
  • 111 Pages
    • |
  • QYResearch
    • |
  • Pharma & Healthcare

Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
The global average price of Guaifenesin (API) is in the decreasing trend, from 8.62 USD/Kg in 2012 to 7.61 USD/Kg in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Guaifenesin (API) includes 98%-99% Guaifenesin and >99% Guaifenesin, and the proportion of >99% Guaifenesin is about 74%, and the proportion is in increasing trend from 2012 to 2016.
Guaifenesin (API) is mainly used in Pharmaceuticals industry. The proportion of Guaifenesin (API) used in Pharmaceuticals industry is about 92%.
The global Guaifenesin (API) market is valued at 56 million US$ in 2018 and will reach 58 million US$ by the end of 2025, growing at a CAGR of 0.5% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Guaifenesin (API) market based on company, product type, end user and key regions.

This report studies the global market size of Guaifenesin (API) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Guaifenesin (API) in these regions.
This research report categorizes the global Guaifenesin (API) market by top players/brands, region, type and end user. This report also studies the global Guaifenesin (API) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Granules
Synthokem Labs
Haizhou Pharma
Yuan Cheng Group
Stellar Chemical
Biesterfeld
Seven Star Pharma
Camlin Fine Science
Gennex Lab
Iwaki Seiyaku
Pan Drugs
Delta Synthetic
Smart Pharm

Market size by Product
98%-99%
>99%
Market size by End User
Pharmaceuticals
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Guaifenesin (API) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Guaifenesin (API) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Guaifenesin (API) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Guaifenesin (API) submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Guaifenesin (API) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Guaifenesin (API) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Guaifenesin (API) Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Guaifenesin (API) Market Size Growth Rate by Product
      • 1.4.2 98%-99%
      • 1.4.3 >99%
    • 1.5 Market by End User
      • 1.5.1 Global Guaifenesin (API) Market Size Growth Rate by End User
      • 1.5.2 Pharmaceuticals
      • 1.5.3 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Guaifenesin (API) Market Size
      • 2.1.1 Global Guaifenesin (API) Revenue 2014-2025
      • 2.1.2 Global Guaifenesin (API) Sales 2014-2025
    • 2.2 Guaifenesin (API) Growth Rate by Regions
      • 2.2.1 Global Guaifenesin (API) Sales by Regions
      • 2.2.2 Global Guaifenesin (API) Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Guaifenesin (API) Sales by Manufacturers
      • 3.1.1 Guaifenesin (API) Sales by Manufacturers
      • 3.1.2 Guaifenesin (API) Sales Market Share by Manufacturers
      • 3.1.3 Global Guaifenesin (API) Market Concentration Ratio (CR5 and HHI)
    • 3.2 Guaifenesin (API) Revenue by Manufacturers
      • 3.2.1 Guaifenesin (API) Revenue by Manufacturers (2014-2019)
      • 3.2.2 Guaifenesin (API) Revenue Share by Manufacturers (2014-2019)
    • 3.3 Guaifenesin (API) Price by Manufacturers
    • 3.4 Guaifenesin (API) Manufacturing Base Distribution, Product Types
      • 3.4.1 Guaifenesin (API) Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Guaifenesin (API) Product Type
      • 3.4.3 Date of International Manufacturers Enter into Guaifenesin (API) Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Guaifenesin (API) Sales by Product
    • 4.2 Global Guaifenesin (API) Revenue by Product
    • 4.3 Guaifenesin (API) Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Guaifenesin (API) Breakdown Data by End User

    6 North America

    • 6.1 North America Guaifenesin (API) by Countries
      • 6.1.1 North America Guaifenesin (API) Sales by Countries
      • 6.1.2 North America Guaifenesin (API) Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Guaifenesin (API) by Product
    • 6.3 North America Guaifenesin (API) by End User

    7 Europe

    • 7.1 Europe Guaifenesin (API) by Countries
      • 7.1.1 Europe Guaifenesin (API) Sales by Countries
      • 7.1.2 Europe Guaifenesin (API) Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Guaifenesin (API) by Product
    • 7.3 Europe Guaifenesin (API) by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Guaifenesin (API) by Countries
      • 8.1.1 Asia Pacific Guaifenesin (API) Sales by Countries
      • 8.1.2 Asia Pacific Guaifenesin (API) Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Guaifenesin (API) by Product
    • 8.3 Asia Pacific Guaifenesin (API) by End User

    9 Central & South America

    • 9.1 Central & South America Guaifenesin (API) by Countries
      • 9.1.1 Central & South America Guaifenesin (API) Sales by Countries
      • 9.1.2 Central & South America Guaifenesin (API) Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Guaifenesin (API) by Product
    • 9.3 Central & South America Guaifenesin (API) by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Guaifenesin (API) by Countries
      • 10.1.1 Middle East and Africa Guaifenesin (API) Sales by Countries
      • 10.1.2 Middle East and Africa Guaifenesin (API) Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Guaifenesin (API) by Product
    • 10.3 Middle East and Africa Guaifenesin (API) by End User

    11 Company Profiles

    • 11.1 Granules
      • 11.1.1 Granules Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Granules Guaifenesin (API) Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Granules Guaifenesin (API) Products Offered
      • 11.1.5 Granules Recent Development
    • 11.2 Synthokem Labs
      • 11.2.1 Synthokem Labs Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Synthokem Labs Guaifenesin (API) Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Synthokem Labs Guaifenesin (API) Products Offered
      • 11.2.5 Synthokem Labs Recent Development
    • 11.3 Haizhou Pharma
      • 11.3.1 Haizhou Pharma Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Haizhou Pharma Guaifenesin (API) Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Haizhou Pharma Guaifenesin (API) Products Offered
      • 11.3.5 Haizhou Pharma Recent Development
    • 11.4 Yuan Cheng Group
      • 11.4.1 Yuan Cheng Group Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Yuan Cheng Group Guaifenesin (API) Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Yuan Cheng Group Guaifenesin (API) Products Offered
      • 11.4.5 Yuan Cheng Group Recent Development
    • 11.5 Stellar Chemical
      • 11.5.1 Stellar Chemical Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Stellar Chemical Guaifenesin (API) Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Stellar Chemical Guaifenesin (API) Products Offered
      • 11.5.5 Stellar Chemical Recent Development
    • 11.6 Biesterfeld
      • 11.6.1 Biesterfeld Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Biesterfeld Guaifenesin (API) Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Biesterfeld Guaifenesin (API) Products Offered
      • 11.6.5 Biesterfeld Recent Development
    • 11.7 Seven Star Pharma
      • 11.7.1 Seven Star Pharma Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Seven Star Pharma Guaifenesin (API) Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Seven Star Pharma Guaifenesin (API) Products Offered
      • 11.7.5 Seven Star Pharma Recent Development
    • 11.8 Camlin Fine Science
      • 11.8.1 Camlin Fine Science Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Camlin Fine Science Guaifenesin (API) Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Camlin Fine Science Guaifenesin (API) Products Offered
      • 11.8.5 Camlin Fine Science Recent Development
    • 11.9 Gennex Lab
      • 11.9.1 Gennex Lab Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Gennex Lab Guaifenesin (API) Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Gennex Lab Guaifenesin (API) Products Offered
      • 11.9.5 Gennex Lab Recent Development
    • 11.10 Iwaki Seiyaku
      • 11.10.1 Iwaki Seiyaku Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Iwaki Seiyaku Guaifenesin (API) Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Iwaki Seiyaku Guaifenesin (API) Products Offered
      • 11.10.5 Iwaki Seiyaku Recent Development
    • 11.11 Pan Drugs
    • 11.12 Delta Synthetic
    • 11.13 Smart Pharm

    12 Future Forecast

    • 12.1 Guaifenesin (API) Market Forecast by Regions
      • 12.1.1 Global Guaifenesin (API) Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Guaifenesin (API) Revenue Forecast by Regions 2019-2025
    • 12.2 Guaifenesin (API) Market Forecast by Product
      • 12.2.1 Global Guaifenesin (API) Sales Forecast by Product 2019-2025
      • 12.2.2 Global Guaifenesin (API) Revenue Forecast by Product 2019-2025
    • 12.3 Guaifenesin (API) Market Forecast by End User
    • 12.4 North America Guaifenesin (API) Forecast
    • 12.5 Europe Guaifenesin (API) Forecast
    • 12.6 Asia Pacific Guaifenesin (API) Forecast
    • 12.7 Central & South America Guaifenesin (API) Forecast
    • 12.8 Middle East and Africa Guaifenesin (API) Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Guaifenesin (API) Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Guaifenesin (API) . Industry analysis & Market Report on Guaifenesin (API) is a syndicated market report, published as Global Guaifenesin (API) Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Guaifenesin (API) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,900.00
      		$5,850.00
      		$7,800.00
      		3,123.90
      		4,685.85
      		6,247.80
      		3,642.60
      		5,463.90
      		7,285.20
      		614,211.00
      		921,316.50
      		1,228,422.00
      		325,221.00
      		487,831.50
      		650,442.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo